Skip to main content
. 2020 Oct 3;5(12):2313–2324. doi: 10.1016/j.ekir.2020.09.019

Table 2.

Patient demographics for the combined KidCOM and C3 Glomerulopathy and Membranoproliferative Glomerulonephritis: Pediatric Outcomes cohorts

Patient demographics Total cohort (N = 165) IC-MPGN (n = 42) C3G (n = 43) P value (IC-MPGN vs. C3G)
Age at diagnosis (yr) 9.3 (8.7–10.0) 9.6 (8.7 – 10.5) 10.1 (9.0–11.3) NS (0.5647)
Age at last follow-up (yr) 13.4 (12.6–14.0) 13.6 (12.5–14.7) 14.1 (13.0–15.2) NS (0.5104)
Follow-up time (yr) 4.0 (3.4–4.6) 4.0 (3.1–5.0) 4.0 (3.1–4.8) NS (0.9072)
Sex
 Male 78 21 15 NS (0.1910)
 Female 87 21 28
Race
 White 109 27 22 NS (0.2744)
 Asian 13 5 4 NS (0.7334)
 American Indian 2 1 0 NS (0.4941)
 Black 13 3 2 NS (0.6761)
 Mixed race 7 4 2 NS (0.4331)
 Native Hawaiian/Pacific Islander 2 0 0 NS (>0.9999)
 Unknown 19 2 13 0.0034a
Weight at diagnosis (kg) 38.6 (34.6–42.6) 36.4 (32.3–40.7) 42.6 (34.4–50.8) NS (0.1883)
Weight at last follow-up (kg) 49.5 (45.6–53.4) 51.4 (45.2–57.6) 52.2 (46.8–57.7) NS (0.8610)
Height at diagnosis (cm) 133.0 (127.9–138.0) 138.1 (132.3–144.0) 135.9 (127.1–144.7) NS (0.6691)
Height at last follow-up (cm) 149.0 (145.0–153.0) 154.0 (148.6–159.4) 155.5 (150.2–160.8) NS (0.6337)

C3G, C3 glomerulopathy; IC-MPGN, immune-complex membranoproliferative glomerulonephritis; NS, not significant.

Numeric data are shown as the mean with 95% confidence interval.

a

Statistically significant.